Plasma BMP9 levels are normal in the majority of PAH patients81 and although circulating activin A is elevated in PAH patients, levels of the endogenous activin antagonist, follistatin, are also increased.120. This evidence concerns the gene GDF2 and pulmonary arterial hypertension.